Zobrazeno 1 - 10
of 29
pro vyhledávání: '"M. F. Brin"'
Autor:
Kimberly R. Byrnes, Richard J. Barohn, Robert C. Griggs, Brian C. Healy, Amanda M. VanDenburgh, Jon Wagg, David J. Loane, Carlos Lopes, Guy J. Buckle, Mark S. Guyer, Noel James Cusack, Amilcar Falcão, Susan A. Gauthier, S. Hua, Michael P. McDermott, Howard L. Weiner, James Stankiewicz, Robyn Guinn, S. Abu-Shakra, M. Vaz-da-Silva, Rebecca A. Betensky, Mark R. Hurtt, Leonel Torrão, Peter Meltzer, Joana Maia, Raquel Costa, Laura Herbelin, José Rocha, Rita Machado, Tatiana Khariton, Mohit Neema, Alan I. Faden, Rui Coelho, Lyndon C. Wright, Zachary D. Guss, Bonnie I. Glanz, Davette Behrens, Ahdeah Pajoohesh-Ganji, Kimberly A. Hart, Jamie Driscoll, Simon Katner, Bruce J. Aungst, Fatta B. Nahab, Ashish Arora, Jason G. Guss, Foster Brown, Antonio Albino-Teixeira, Dominik S. Meier, Samia J. Khoury, M. F. Brin, Ingrid Li, Noel J. Cusack, Charles R.G. Guttmann, Christine Thorne, Patrício Soares-da-Silva, Svetlana Egorova, Mark Hallett, Bruce Solomon, Manasee V. Shah, Lata Venkatarangan, Zsuzsanna Liptak, Candace Rohde, Teresa G. Nunes, F. C. Beddingfield, Barbara E. Herr, Yong Yao, Rohit Bakshi, A. I. Loureiro, Luis Almeida, John Torchia, Linda S. Brady, Bogdan A. Stoica, Loretta Wittevrongel
Publikováno v:
Neurotherapeutics. 5:490-495
Background and Objective An assessment of clinically important change is useful in interpreting clinical trial outcomes. The 4-point Ashworth Scale (AS) is a widely accepted measure of muscle tone, and the 9-point Physician Global Assessment Score (P
Publikováno v:
Journal of Neural Transmission. 111:1333-1341
Although improved cognition has been reported in patients with mild Parkinson's disease (PD) following the administration of levodopa, mixed results have been found in moderately-to-severely affected PD patients (MSPD), particularly in studies conduc
Autor:
J. S. Fink, J. H. Growdon, W. Koller, C. W. Olanow, J. B. Bennett, Roger Kurlan, Christopher G. Goetz, P. LeWitt, O. Suchowersky, G. Paulson, K. Shannon, G. F. Wooten, A. H. Rajput, Joseph H. Friedman, S. Gancher, M. F. Brin, J. Nutt, Robert L. Rodnitzky, C. Tanner
Publikováno v:
New England Journal of Medicine. 328:176-183
In 1987 we began a multicenter controlled clinical trial of deprenyl (a monoamine oxidase inhibitor) and tocopherol (a component of vitamin E that traps free radicals) in the treatment of early Parkinson's disease. We randomly assigned 800 patients t
Publikováno v:
Neuroacanthocytosis Syndromes II ISBN: 9783540716921
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb0ead16d19aba19779d906674428164
https://doi.org/10.1007/978-3-540-71693-8_17
https://doi.org/10.1007/978-3-540-71693-8_17
Publikováno v:
Journal Club Schmerzmedizin. 3:131-131
Bei chronischer Migrane ist Onabotulinumtoxin A (eine Form des Botulinum-Toxins) zur Prophylaxe zugelassen. Dabei haben 2 offene Phase-II-Studien und 2 Phase-III-Doppelblindstudien positive Wirksamkeit gezeigt, was die Symptomatik und die gesundheits
Publikováno v:
Neurology. 55(12 Suppl 5)
Botulinum toxin is the most neurotoxic substance known, with a specific action at cholinergic synapses. Acting as a zinc endopeptidase, botulinum toxin cleaves specific proteins involved in vesicle fusion, thereby preventing release of acetylcholine.
Publikováno v:
Neurology. 55(12 Suppl 6)
Patients with advanced Parkinson's disease (PD) frequently suffer disabling motor complications that cannot be satisfactorily controlled with medical therapy. Deep brain stimulation (DBS) has recently been introduced by Benabid and his colleagues in
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 15(6)
Fourteen patients with primary or secondary dystonia received intrathecal baclofen (ITB) through an implanted pump following a trial dose. Patients were selected for ITB trial if they had clinically unsatisfactory responses to oral antidystonic medic
Publikováno v:
Neuropsychiatry, neuropsychology, and behavioral neurology. 13(3)
This technical report and feasibility study propose a standardized method for collecting neuropsychological data in patients undergoing the deep brain stimulation (DBS) procedure.Programs for standardizing motor data collected in studies investigatin
Autor:
C, Klein, N, Gurvich, M, Sena-Esteves, S, Bressman, M F, Brin, B J, Ebersole, S, Fink, L, Forsgren, J, Friedman, D, Grimes, G, Holmgren, M, Kyllerman, A E, Lang, D, de Leon, J, Leung, C, Prioleau, D, Raymond, G, Sanner, R, Saunders-Pullman, P, Vieregge, J, Wahlström, X O, Breakefield, P L, Kramer, L J, Ozelius, S C, Sealfon
Publikováno v:
Annals of neurology. 47(3)
A novel Val154--Ile mutation in the D2 dopamine receptor (DRD2) on chromosome 11q23 has recently been shown to be associated with myoclonus dystonia (M-D) in one large family. Sequence analysis of the DRD2 gene in 5 M-D patients from different famili